The National Institutes of Health (NIH) has selected Joshua Denny, MD, MS, vice president of Personalized Medicine at Vanderbilt University Medical Center, to be the chief executive officer of the federal All of Us Research Program.
A drug used to treat and prevent HIV/AIDS is showing promise as a potential therapy for Alzheimer’s disease, and Vanderbilt University biochemist F. Peter Guengerich, PhD, is aiding efforts to make this approach to improving memory and cognitive function even better.
Through a record $11.9 billion in annual economic impact, Vanderbilt University’s deep and broad connections to Tennessee and its people continue to be key and growing drivers of the state’s economy and to the vitality and well-being of its citizens and communities.
